Inspire Medical Systems, Inc. $INSP Shares Bought by Eventide Asset Management LLC

Eventide Asset Management LLC grew its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 71.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 440,205 shares of the company’s stock after purchasing an additional 183,547 shares during the quarter. Eventide Asset Management LLC’s holdings in Inspire Medical Systems were worth $40,601,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in INSP. M&T Bank Corp acquired a new stake in Inspire Medical Systems during the 4th quarter worth $85,871,000. Deerfield Management Company L.P. boosted its stake in Inspire Medical Systems by 648.4% during the 3rd quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock worth $77,739,000 after purchasing an additional 907,694 shares during the last quarter. Morgan Stanley boosted its stake in Inspire Medical Systems by 179.5% during the 4th quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock worth $116,188,000 after purchasing an additional 809,121 shares during the last quarter. Fuller & Thaler Asset Management Inc. acquired a new stake in Inspire Medical Systems during the 4th quarter worth $61,619,000. Finally, Balyasny Asset Management L.P. boosted its stake in Inspire Medical Systems by 16,504.3% during the 3rd quarter. Balyasny Asset Management L.P. now owns 614,359 shares of the company’s stock worth $45,585,000 after purchasing an additional 610,659 shares during the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Trading Up 0.7%

Shares of INSP stock opened at $42.74 on Friday. The company’s 50-day moving average price is $48.05 and its 200-day moving average price is $71.79. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of 9.52, a PEG ratio of 4.41 and a beta of 0.73. Inspire Medical Systems, Inc. has a twelve month low of $38.91 and a twelve month high of $147.03.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Monday, May 4th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.38. The firm had revenue of $204.58 million for the quarter, compared to analysts’ expectations of $200.04 million. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The company’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, equities research analysts predict that Inspire Medical Systems, Inc. will post 0.91 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Zacks Research cut shares of Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 13th. Weiss Ratings cut shares of Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, May 6th. Bank of America cut shares of Inspire Medical Systems from a “neutral” rating to an “underperform” rating and set a $39.00 target price on the stock. in a research note on Friday, May 22nd. Royal Bank Of Canada lowered their price target on shares of Inspire Medical Systems from $56.00 to $45.00 and set a “sector perform” rating on the stock in a research report on Tuesday, May 5th. Finally, Robert W. Baird lowered their price target on shares of Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Four investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Hold” and a consensus target price of $81.84.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.